India’s first quadrivalent flu vaccine to offer better protection against influenza A and B strains. Experts stress the ...

Zydus Lifesciences on Wednesday said it is introducing a vaccine for protection against new strain of influenza virus.

New Delhi: Accepting the bioequivalence study report for Type 2 Diabetes Mellitus, the Subject Expert Committee (SEC) ...

A global collaboration towards a secure supply-chain or a differentiated manufacturing model are just some of the options ...

Zydus Lifesciences introduces India's first quadrivalent influenza vaccine, VaxiFlu-4, offering protection against four new ...

Zydus Lifesciences to launch VaxiFlu-4 vaccine for 2025 southern hemisphere, offering broad protection against influenza ...

Zydus on Wednesday announced that it is ready to launch the season’s first India’s Flu protection as per WHO recommended ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

The Indian pharmaceutical industry has the potential to deliver 100 new drugs for global markets by 2047, driven by enhanced ...

Zydus Lifesciences introduces India's first quadrivalent influenza vaccine, VaxiFlu-4, for protection against four new virus ...

India's first quadrivalent influenza vaccine, for the 2025 southern hemisphere season. A quadrivalent vaccine, by covering strains of both influenza A and influenza B, provides broader protection and ...

Zydus Lifesciences on Wednesday (February 26, 2025) said it is introducing a vaccine for protection against new strain of influenza virus. “The company is introducing country’s first flu ...